Author: admin
Precision BioSciences Announces Formation of Scientific Advisory Board With Anderson, Kantarjian, Schinazi and Turtle
DURHAM, North Carolina, USA, January 16, 2019 – Precision BioSciences today announced the formation of its Scientific Advisory Board (SAB) with four key appointments: Kenneth C. Anderson, MD,...
Science Article About the Quest to Cure HBV Brings Context to Precision BioSciences Collaboration With Gilead
Precision BioSciences is pleased to be part of this important feature story from Science Magazine: Forgotten No More – A long-overlooked scourge of millions, hepatitis B is in the crosshairs...
Precision BioSciences Receives the 2018 SEBIO Venture Funding Award
DURHAM, North Carolina, USA, November 15, 2018 – Precision BioSciences announced today that it has been recognized as the recipient of the 2018 Southeast BIO (SEBIO) Venture Funding Award. Abid...
Precision BioSciences and MaxCyte Enter Into Clinical and Commercial License Agreement
Precision BioSciences is pleased to be working with MaxCyte. Read more about our clinical and commercial license agreement to use the MaxCyte electroporation system for non-viral delivery of genome...
Mario G. Pennisi, Australian Life Sciences Industry Leader, Joins Elo-Australia as Resident Director
RESEARCH TRIANGLE PARK, North Carolina, USA and BRISBANE, Australia, October 10, 2018 – Elo Life Systems Inc. announced today that Mario G. Pennisi joined Elo Life Systems as a Resident...
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
FOSTER CITY, Calif. and DURHAM, NC, Sept 12, 2018 – Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the companies have entered into a strategic collaboration to...
Precision BioSciences Announces Collaboration With University of Pennsylvania to Develop Genome Editing Therapeutics
DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine...
CSO Derek Jantz Discusses Precision's Long History in Genome Editing and the Future of Medicine with PMWC
Precision BioSciences CSO and Co-founder Derek Jantz will present during the Emerging Therapeutics Showcase of the Duke Precision Medicine World Conference (PMWC) on September 25th, 2018 in Durham,...
Penn Announces Publication of Clinically Relevant Genome Editing in Primates Using Precision's ARCUS Platform
Durham, NC July 09, 2018 – The University of Pennsylvania’s Perelman School of Medicine announced today that researchers from Jim Wilson’s Gene Therapy Program have found that using...
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
DURHAM, North Carolina, USA, June 26 2018 –Precision BioSciences today announced the closing of an oversubscribed $110M Series B financing to further product development efforts based on its...
Precision BioSciences CSO to Join Gene Therapy Session at DIA 2018
DURHAM, North Carolina, USA, June 20 2018 – Precision BioSciences CSO Derek Jantz will present and join a panel discussion during the DIA (Drug Information Association) 2018 conference session...
Precision PlantSciences Renamed Elo Life Systems
DURHAM, North Carolina, USA, June 04 2018 – Precision BioSciences has announced a new name and brand identity for its food and agriculture business. The new entity, Elo Life Systems, will be held...
Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
DURHAM, North Carolina, USA, May 14 2018 – Precision BioSciences, the ARCUS genome editing company with novel product development programs in gene therapy, cancer immunotherapy and non-GMO food,...
Cargill Announces Ongoing Partnership With Precision BioSciences Enabling Healthy Canola Oil Products
Durham, NC Feb. 22, 2018 – Cargill today announced an ongoing partnership with Precision BioSciences to advance its program in healthy canola oils with the lowest saturate levels on the market...
Precision CEO Matt Kane Discusses the Unique Features of ARCUS With PMWC
On January 22nd 2018, Precision BioSciences CEO and Co-founder Matt Kane will participate in the Silicon Valley Precision Medicine World Conference (PMWC), sharing his insights as part of...